Chronic progressive external ophthalmoplegia: A report of 6 cases and a review of the literature

Neurologist

Volumn 13, Issue 1, 2007, Pages 33-36

  Caballero, Pedro Enrique Jiménez ^a,b   Candela, Monica Serviá ^a   Álvarez, Clara Isabel Cabeza ^a   Tejerina, Araceli Álvarez ^a  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b NONE   (Spain)

Author keywords

Chronic progressive external ophthalmoplegia; Jitter; Mitochondrial disease; Ragged red fibers

Indexed keywords

CHOLINERGIC RECEPTOR; CREATINE KINASE; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; DYSPHAGIA; FEMALE; GENE DELETION; GENETIC DAMAGE; HUMAN; MALE; NERVOUSNESS; PATIENT INFORMATION; PRIORITY JOURNAL; PTOSIS; RETROSPECTIVE STUDY;

ADULT; AGE OF ONSET; AGED; ANTIBODIES; BLEPHAROPTOSIS; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; OPHTHALMOPLEGIA, CHRONIC PROGRESSIVE EXTERNAL; RECEPTORS, CHOLINERGIC; REVIEW LITERATURE;

EID: 33846257636     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nrl.0000252953.49721.f5     Document Type: Article

References (29)

1. Hart PE, De Vivo DC, Schapira AH. Clinical features of the mitochondrial encephalomyopathies. In: Shapira AH, DiMauro S, eds. Mitochondrial Disorders in Neurology 2. Woburn: Butterworth-Heineman; 2002:35-68.
2. Rowland LP, Blake DM, Hirano M, et al. Clinical syndromes associated with ragged red fibers. Rev Neurol (Paris). 1991;147:467-473.
3. Hammans SR, Sweeney MG, Brockington M, et al. Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples. Lancet. 1991;337:1311-1313.
4. Truong DD, Harding AE, Scavallini F, et al. Movement disorders in mitochondrial myopathies: a study of nine cases with two autopsy studies. Mov Disord. 1990;5:109-117.
5. Berenberg RA, Pellock JM, DiMauro S, et al. Lumping or splitting? "ophthalmoplegia-plus" or Kearns-Sayre syndrome? Ann Neurol. 1977;1:37-54.
6. Walker UA, Collins S, Byrne E. Respiratory chain encephalomyopathies: a diagnostic classification. Eur Neurol. 1996;36:260-267.
7. Cesen W, Engel WK, Walsh GO, et al. Oculocraneosomatic neuromuscular disease with ragged-red fibers. Arch Neurol. 1972;26:193-211.
8. Deschauer M, Muller T, Dreha S, et al. Familiar mitochondrial chronic progressive external ophthalmoplegia: five families with differing genetics. Nervenarzt. 2001;72:122-129.
9. Arpa-Gutierrez FJ, Cruz-Martinez A, Campos-Gonzalez Y, et al. Mitochondrial respiratory chain diseases: evaluation and variability in 52 patients. Rev Neurol. 2005;41:449-454.
10. Petty RK, Harding AE, Morgan-Hughes JA. The clinical features of mitochondrial myopathy. Brain. 1986;109:915-938.
11. Becker R, Laube H, Laube H, et al. Impaired glucose effectiveness in chronic progressive external ophthalmoplegia. Metabolism. 2002;51:796-800.
12. Okulla T, Kunz WS, Klockgether T, et al. Diagnosis value of mitochondrial DNA mutation analysis in juvenile unilateral ptosis. Graefes Arch Clin Ophthalmol. 2005;243:380-382.
13. Rossier J, Hatt M. Atypical manifestation of progressive external opthalmoplegia. Klin Monatsld Augenheilkd. 1996;208:366-367.
14. Richardson C, Smith T, Schaefer A, et al. Ocular motility findings in chronic progressive external ophthalmoplegia. Eye. 2005;19:258-263.
15. Mitsikotas D, Manta P, Kalfakis N, et al. External ophthalmoplegia with ragged-red fibers and acetylcholine receptor antibodies. Funct Neurol. 1995;10:209-215.
16. Roberts NK, Perloff JK, Kark RA. Cardiac conduction in Kearns-Sayre syndrome (a neuromuscular disorder associated with progressive external ophthalmoplegia, and pigmentary retinopathy): report of 2 cases and review of 17 published cases. Am J Cardiol. 1979;44:1396-1400.
17. Schaefer AM, Blakely EL, Griffiths PG, et al. Ophthalmoplegia due to mitochondrial DNA disease: the need for genetic diagnosis. Muscle Nerve. 2005;32:104-107.
18. Kornblum C, Kunz WS, Klockgether T, et al. Diagnostic value of mitochondrial DNA analysis in chronic progressive external ophthalmoplegia (CPEO). Klin Monatsbl Augenheilkd. 2004;221:1057-1061.
19. Pineda M, Playan-Ariso A, Alcaine-Villarroya MJ, et al. Familiar chronic progressive external ophthalmoplegia of mitochondrial origin. Rev Neurol. 2004;38:1023-1027.
20. Drouet A. Chronic progressive external ophthalmoplegia with mitochondrial: clinical, histological, biochemical and genetic analysis. Rev Med Intern. 1996;17:200-206.
21. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature. 1988;331:717-719.
22. Holt IJ, Harding AE, Cooper JM, et al. Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol. 1989;26:699-708.
23. Moraes CT, DiMauro S, Zeviani M, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med. 1989;320:1293-1299.
24. Mariotti C, Savarese N, Soumalainen A, et al. Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of the mitochondrial DNA. J Neurol. 1995;242:304-312.
25. Hansrote C, Croul S, Selak M, et al. External ophthalmoplegia with severe progressive multiorgan involvement associated with the mtDNA A3243G mutation. J Neurol Sci. 2002;197:63-67.
26. Koga Y, Koga A, Iwanaga R, et al. Single-fiber analysis of mitochondrial A3243G mutation in four different phenotypes. Acta Neuropathol (Berl). 2000;99:186-190.
27. Wong VA, Becningsale PS, Oley CA, et al. Management of myogenic ptosis. Ophthalmology. 2002;109:1023-1031.
28. Daut PM, Steinemann TL, Westfall CT. Chronic exposure keratopathy complicating surgical correction of ptosis in patients with chronic progressive ophthalmoplegia. Am J Ophthalmol. 2000;130:519-521.
29. Cohen JM, Waiss B. Combination ptosis crutch and moisture chamber for management of progressive external ophthalmoplegia. J Am Optom Assoc. 1997;155:57-58.